Marpai (MRAI) Competitors $1.05 +0.10 (+10.40%) As of 04/17/2025 02:12 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock MRAI vs. OPGN, BNR, CCM, ENZ, BRTX, KDLY, MGRX, OTRK, SSY, and ATPCShould you be buying Marpai stock or one of its competitors? The main competitors of Marpai include OpGen (OPGN), Burning Rock Biotech (BNR), Concord Medical Services (CCM), Enzo Biochem (ENZ), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Mangoceuticals (MGRX), Ontrak (OTRK), SunLink Health Systems (SSY), and Agape ATP (ATPC). These companies are all part of the "healthcare" industry. Marpai vs. OpGen Burning Rock Biotech Concord Medical Services Enzo Biochem BioRestorative Therapies Kindly MD Mangoceuticals Ontrak SunLink Health Systems Agape ATP Marpai (NASDAQ:MRAI) and OpGen (NASDAQ:OPGN) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, community ranking, media sentiment and institutional ownership. Does the MarketBeat Community believe in MRAI or OPGN? OpGen received 299 more outperform votes than Marpai when rated by MarketBeat users. However, 66.67% of users gave Marpai an outperform vote while only 52.17% of users gave OpGen an outperform vote. CompanyUnderperformOutperformMarpaiOutperform Votes266.67% Underperform Votes133.33% OpGenOutperform Votes30152.17% Underperform Votes27647.83% Which has higher valuation & earnings, MRAI or OPGN? Marpai has higher revenue and earnings than OpGen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMarpai$34.87M0.45-$28.75M-$2.07-0.51OpGen$2.67M13.04-$32.67MN/AN/A Which has more risk & volatility, MRAI or OPGN? Marpai has a beta of 4.75, meaning that its share price is 375% more volatile than the S&P 500. Comparatively, OpGen has a beta of -1.61, meaning that its share price is 261% less volatile than the S&P 500. Is MRAI or OPGN more profitable? Marpai has a net margin of -85.70% compared to OpGen's net margin of -1,140.36%. Company Net Margins Return on Equity Return on Assets Marpai-85.70% N/A -100.23% OpGen -1,140.36%N/A -287.58% Do insiders & institutionals have more ownership in MRAI or OPGN? 49.8% of Marpai shares are owned by institutional investors. Comparatively, 2.7% of OpGen shares are owned by institutional investors. 61.3% of Marpai shares are owned by insiders. Comparatively, 43.8% of OpGen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media refer more to MRAI or OPGN? In the previous week, Marpai had 1 more articles in the media than OpGen. MarketBeat recorded 1 mentions for Marpai and 0 mentions for OpGen. Marpai's average media sentiment score of 0.00 equaled OpGen'saverage media sentiment score. Company Overall Sentiment Marpai Neutral OpGen Neutral SummaryMarpai beats OpGen on 9 of the 11 factors compared between the two stocks. Get Marpai News Delivered to You Automatically Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRAI vs. The Competition Export to ExcelMetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ ExchangeMarket Cap$15.64M$1.89B$6.97B$7.35BDividend YieldN/A7.10%2.69%4.30%P/E Ratio-0.4014.7129.4217.81Price / Sales0.454.18163.3797.70Price / CashN/A9.3231.6134.64Price / Book-0.613.994.543.98Net Income-$28.75M$87.49M$195.94M$247.81M1 Month Performance9.38%-13.20%-9.48%-7.94%1 Year Performance-54.94%-31.79%4.62%1.52% Marpai Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRAIMarpaiN/A$1.05+10.4%N/A-57.7%$15.64M$34.87M-0.40150Gap UpOPGNOpGenN/A$4.04+3.6%N/A-32.3%$33.76M$2.67M0.00100Analyst ForecastGap DownBNRBurning Rock Biotech0.4997 of 5 stars$2.91-3.3%N/A-65.0%$29.81M$515.82M-0.971,390CCMConcord Medical Services0.3934 of 5 stars$4.22+5.0%N/A-28.1%$18.32M$471.70M0.00970Analyst ForecastNews CoverageGap DownHigh Trading VolumeENZEnzo Biochem0.5554 of 5 stars$0.35+6.5%N/A-71.2%$18.08M$29.09M0.00520Analyst ForecastGap DownBRTXBioRestorative Therapies3.6065 of 5 stars$1.78-0.6%$18.00+911.2%+21.5%$13.36M$401,000.00-1.167Short Interest ↓Gap DownKDLYKindly MD0.1583 of 5 stars$1.66-3.5%N/AN/A$10.37M$2.72M-2.52N/ANews CoverageGap UpMGRXMangoceuticals0.41 of 5 stars$1.82+16.3%N/A-96.2%$9.41M$615,873.00-0.313Short Interest ↑OTRKOntrak2.811 of 5 stars$1.66+5.8%$45.00+2,610.8%-65.8%$7.00M$11.24M-0.16250Earnings ReportShort Interest ↓SSYSunLink Health SystemsN/A$0.85-4.7%N/A+36.0%$5.97M$31.23M6.061,376Analyst ForecastATPCAgape ATP0.8244 of 5 stars$1.42+7.6%N/A-61.0%$5.67M$1.32M-1.9540Gap Up Related Companies and Tools Related Companies OpGen Competitors Burning Rock Biotech Competitors Concord Medical Services Competitors Enzo Biochem Competitors BioRestorative Therapies Competitors Kindly MD Competitors Mangoceuticals Competitors Ontrak Competitors SunLink Health Systems Competitors Agape ATP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MRAI) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
